Cameroon vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Europe (WHO region)
90.0%
in 2024
Cameroon rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Europe (WHO region)
How they compare
Cameroon currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Cameroon's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 5 times across 15 shared years of data; in 2009 it was Europe (WHO region) ahead.
Cameroon ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Europe (WHO region) in 2.
Head to head by decade
| Decade | Cameroon | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 42.0% | 28.0% | Europe (WHO region) |
| 2010s | 52.8% | 60.2% | 7.4% | Europe (WHO region) |
| 2020s | 97.2% | 93.8% | 3.4% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Europe (WHO region)?
- Cameroon, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Europe (WHO region)?
- 10.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Europe (WHO region)?
- 15 years are reported by both, from 2009 to 2024.
- How do Cameroon and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.